Teva Pharmaceutical Indus...

16.46
0.21 (1.29%)
At close: Feb 18, 2025, 3:59 PM
16.66
1.20%
After-hours: Feb 18, 2025, 07:56 PM EST
undefined%
Bid 16.66
Market Cap 18.67B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -1.45
PE Ratio (ttm) -11.36
Forward PE n/a
Analyst Buy
Ask 16.85
Volume 13,772,313
Avg. Volume (20D) 11,763,684
Open 17.15
Previous Close 16.25
Day's Range 16.34 - 17.15
52-Week Range 12.51 - 22.80
Beta undefined

About TEVA

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and cr...

Sector Healthcare
IPO Date Feb 16, 1982
Employees 33,892
Stock Exchange NYSE
Ticker Symbol TEVA
Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for TEVA stock is "Buy." The 12-month stock price forecast is $24.5, which is an increase of 48.80% from the latest price.

Buy 83.33%
Hold 16.67%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Teva Pharmaceutical Industries Limited is scheduled to release its earnings on May 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
+1.97%
Teva shares are trading higher after the FDA accep... Unlock content with Pro Subscription
2 weeks ago
-3.78%
Teva Pharmaceutical shares are trading lower after Barclays cut its price target on the stock from $28 to $26.